Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP332358.RAUUBrKxnZzaAQNkKhzgrDgtOJCEUczMVTLVgDCHdZG6A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP332358.RAUUBrKxnZzaAQNkKhzgrDgtOJCEUczMVTLVgDCHdZG6A130_assertion type Assertion NP332358.RAUUBrKxnZzaAQNkKhzgrDgtOJCEUczMVTLVgDCHdZG6A130_head.
- NP332358.RAUUBrKxnZzaAQNkKhzgrDgtOJCEUczMVTLVgDCHdZG6A130_assertion description "[To determine the specificity of the effects produced by DES and PDB the cells were treated with estrogen receptor antagonist tamoxifen and protein kinase C (PKC) specific inhibitor chelerythrine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332358.RAUUBrKxnZzaAQNkKhzgrDgtOJCEUczMVTLVgDCHdZG6A130_provenance.
- NP332358.RAUUBrKxnZzaAQNkKhzgrDgtOJCEUczMVTLVgDCHdZG6A130_assertion evidence source_evidence_literature NP332358.RAUUBrKxnZzaAQNkKhzgrDgtOJCEUczMVTLVgDCHdZG6A130_provenance.
- NP332358.RAUUBrKxnZzaAQNkKhzgrDgtOJCEUczMVTLVgDCHdZG6A130_assertion SIO_000772 12231395 NP332358.RAUUBrKxnZzaAQNkKhzgrDgtOJCEUczMVTLVgDCHdZG6A130_provenance.
- NP332358.RAUUBrKxnZzaAQNkKhzgrDgtOJCEUczMVTLVgDCHdZG6A130_assertion wasDerivedFrom befree-20140225 NP332358.RAUUBrKxnZzaAQNkKhzgrDgtOJCEUczMVTLVgDCHdZG6A130_provenance.
- NP332358.RAUUBrKxnZzaAQNkKhzgrDgtOJCEUczMVTLVgDCHdZG6A130_assertion wasGeneratedBy ECO_0000203 NP332358.RAUUBrKxnZzaAQNkKhzgrDgtOJCEUczMVTLVgDCHdZG6A130_provenance.